|
rs1042579
|
|
|
0.040 |
GeneticVariation |
BEFREE |
Thrombomodulin -33G/A and Ala455Val polymorphisms are associated with the risk of coronary artery disease: a meta-analysis including 12 584 patients.
|
25144670 |
2015 |
|
rs1042579
|
|
|
0.040 |
GeneticVariation |
BEFREE |
A combination of two common thrombomodulin gene variants (-1208-1209TTdelTT and A455V) influence risk of coronary heart disease: a prospective study in men.
|
15488871 |
2004 |
|
rs1042579
|
|
|
0.040 |
GeneticVariation |
BEFREE |
In smokers, the thrombomodulin Ala455Val variant allele emerges as a significant risk factor for coronary heart disease.
|
14523329 |
2003 |
|
rs1042620356
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Compound mutants for (MTHFD-G1958A, MTHFR-C677T and MTR-A2756G) and (MTHFD-G1958A, RFC1-G80A and MTR-A2756G) may increase the risk of CHD.
|
23701284 |
2013 |
|
rs1042713
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Cigarette smoking, carrier state of A or G allele of 46A>G and 79C>G polymorphisms of beta2-adrenergic receptor gene, and the risk of coronary artery disease.
|
18473266 |
2008 |
|
rs1042713
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Common Arg16Gly and Gln27Glu polymorphisms of the beta(2)-adrenergic receptor (beta(2)AR) have been associated with hypertension and coronary disease.
|
15797659 |
2005 |
|
rs1042714
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Common Arg16Gly and Gln27Glu polymorphisms of the beta(2)-adrenergic receptor (beta(2)AR) have been associated with hypertension and coronary disease.
|
15797659 |
2005 |
|
rs1042714
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Cigarette smoking, carrier state of A or G allele of 46A>G and 79C>G polymorphisms of beta2-adrenergic receptor gene, and the risk of coronary artery disease.
|
18473266 |
2008 |
|
rs1042714
|
|
|
0.030 |
GeneticVariation |
BEFREE |
To examine the role of the Gln27Glu polymorphism of β2-AR in HF development and to assess the hypothesis that Gln27Glu is associated with coronary artery disease in patients with ischaemic HF.
|
28933308 |
2018 |
|
rs10431335
|
|
|
0.700 |
GeneticVariation |
GWASDB |
A genome-wide association study of a coronary artery disease risk variant.
|
23364394 |
2013 |
|
rs1043618
|
|
|
0.010 |
GeneticVariation |
BEFREE |
By resequencing and genotyping, the associations of 2 single nucleotide polymorphisms (SNPs) +190G/C (rs1043618) and -110A/C (rs1008438) in the HSPA1A gene with risk of CHD were determined in a 1,003 pairs case-control study.
|
19333379 |
2009 |
|
rs1044250
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Circulating Angptl4 levels may not influence TG levels or CHD risk for the following reasons: (1) Angptl4 levels were not correlated with TGs; (2) T266M, although associated with Angptl4 levels, showed no association with plasma TGs; and (3) TG-lowering E40K did not influence Angptl4 levels.
|
20829508 |
2010 |
|
rs1044925
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Association between single nucleotide polymorphism rs1044925 and the risk of coronary artery disease and ischemic stroke.
|
24577316 |
2014 |
|
rs10455872
|
|
G |
0.830 |
GeneticVariation |
GWASCAT |
Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.
|
28753643 |
2017 |
|
rs10455872
|
|
|
0.830 |
GeneticVariation |
BEFREE |
For the best SNP rs10455872 for plasma Lp(a) levels, the OR for CHD, CVD, and CVD death was 0.94 (95% CI: 0.69-1.28), 0.97 (0.72-1.29), and 1.23 (0.79-1.92), respectively.
|
21900290 |
2012 |
|
rs10455872
|
|
|
0.830 |
GeneticVariation |
GWASCAT |
Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants.
|
24262325 |
2014 |
|
rs10455872
|
|
|
0.830 |
GeneticVariation |
GWASDB |
Large-scale gene-centric analysis identifies novel variants for coronary artery disease.
|
21966275 |
2011 |
|
rs10455872
|
|
|
0.830 |
GeneticVariation |
BEFREE |
In the replication cohort, rs10455872 was also associated with CHD events (odds ratio, 1.71; 95% confidence interval, 1.14-2.57; P=0.009).
|
29703846 |
2018 |
|
rs10455872
|
|
|
0.830 |
GeneticVariation |
BEFREE |
Extreme lipoprotein(a) levels or corresponding LPA KIV-2/rs10455872 risk genotypes substantially improved MI and CHD risk prediction.
|
23375930 |
2013 |
|
rs1045642
|
|
|
0.040 |
GeneticVariation |
BEFREE |
The association of MDR1 C3435T and G2677T/A polymorphisms with plasma platelet-activating factor levels and coronary artery disease risk in Turkish population.
|
23816407 |
2013 |
|
rs1045642
|
|
|
0.040 |
GeneticVariation |
BEFREE |
The C3435T polymorphism in the ABCB1 gene of fetus increases the risks of CHD in a Han Chinese population when the mothers are exposed to phthalates and alkylphenolic compounds during the periconceptional period, particularly for septal defects.
|
23874772 |
2013 |
|
rs1045642
|
|
|
0.040 |
GeneticVariation |
BEFREE |
The current meta-analysis suggests that ABCB1 C3435T polymorphism may contribute to the risk of CHD, especially for MI and ACS, among Caucasian populations.
|
24328528 |
2014 |
|
rs1045642
|
|
|
0.040 |
GeneticVariation |
BEFREE |
We sought to investigate maternal and child functional MDR1 C3435T polymorphism, periconception medication, folic acid use, and the risk of a congenital heart defect (CHD) in the offspring.
|
21183151 |
2011 |
|
rs10468017
|
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project.
|
21347282 |
2011 |
|
rs10484404
|
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study of coronary artery disease in the Japanese.
|
21971053 |
2012 |